BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31939390)

  • 61. The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective.
    Hirani R; Peberdy J; Mondy P
    Transfus Apher Sci; 2018 Apr; 57(2):239-242. PubMed ID: 29530405
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plateletpheresis-induced increase in platelet reactivity using different cell separators.
    Jung F; Bläsi U; Radtke H; Mrowietz C; Pindur G; Kiesewetter H; Wenzel E
    Infusionsther Transfusionsmed; 1995 Aug; 22(4):237-43. PubMed ID: 7496123
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Donor platelet response and product quality assurance in plateletpheresis.
    Lasky LC; Lin A; Kahn RA; McCullough J
    Transfusion; 1981; 21(3):247-60. PubMed ID: 7233509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Switching iron-deficient whole blood donors to plateletpheresis.
    O'Meara A; Infanti L; Sigle J; Stern M; Buser A
    Transfusion; 2012 Oct; 52(10):2183-8. PubMed ID: 22404849
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of Frequency of Platelet Apheresis on Coagulation Function in Donors: A Prospective Cohort Study.
    Feng Q; Zhu F; Li C; Guo B; Ye J; Chen J
    Indian J Hematol Blood Transfus; 2019 Oct; 35(4):736-741. PubMed ID: 31741630
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Plateletpheresis efficiency: a comparison of the spectra LRS and AMICUS separators.
    Benjamin RJ; Rojas P; Christmas S; Neal J; Broughton S; Burgio C; Barrett B; Churchill WH
    Transfusion; 1999 Aug; 39(8):895-9. PubMed ID: 10504127
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Periodic acid-Schiff (PAS) staining of immature platelets in donors.
    Pogorelov VM; Beskorovainova VJ; Chanieva MI; Dyagileva OA; Naumova IN; Skedina MA
    Platelets; 2012; 23(1):51-9. PubMed ID: 21736421
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regular plateletpheresis increased basal concentrations of soluble P-selectin in healthy donors: Possible involvement of endothelial cell activation?
    Chen Y; Lin Y; Lin H; Xiao J; Jiang L; Chen C; Zhuo X; Huang W; Zeng J; Dettke M
    Clin Chim Acta; 2016 Jul; 458():18-22. PubMed ID: 27108199
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effects of warming methods on temperature, cardiac function and cytokines in plateletpheresis donors.
    Kim HJ; Kim NC; Park CW
    Vox Sang; 2008 Jul; 95(1):45-51. PubMed ID: 18380771
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators.
    Perseghin P; Mascaretti L; Speranza T; Belotti D; Baldini V; Dassi M; Riva M; Pogliani EM; Sciorelli G
    Transfusion; 2004 Jan; 44(1):125-30. PubMed ID: 14692978
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors.
    Lokhande T; Thomas S; Kumar G; Bajpai M
    Indian J Hematol Blood Transfus; 2021 Apr; 37(2):295-301. PubMed ID: 33867737
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pseudothrombocytopenia in plateletpheresis donors.
    Sweeney JD; Holme S; Heaton WA; Campbell D; Bowen ML
    Transfusion; 1995 Jan; 35(1):46-9. PubMed ID: 7998068
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of plateletpheresis with two different cell separators using 100 identical donors.
    Wiesneth M; Freudenberg J; Platow S; Kalinova J; Vogel M; Kubanek B
    Beitr Infusionsther; 1991; 28():201-3. PubMed ID: 1725619
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of plateletpheresis on haematological values in voluntary donors: a retrospective data analysis over an eight-month period.
    Ahmetović-Karić G; Ćatović-Baralija E; Mehić K
    Med Glas (Zenica); 2024 Feb; 21(1):16-22. PubMed ID: 38341680
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessing the performance of a plateletpheresis unit at a tertiary-care academic medical center in Mexico: A 6-year experience.
    Jaime-Pérez JC; Beltrán-López AL; Alvarado-Navarro DM; Espinoza-Mares M; Ancer-Rodríguez J; Gómez-Almaguer D
    J Clin Apher; 2021 Dec; 36(6):808-814. PubMed ID: 34411330
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator.
    Chaudhary R; Das SS; Khetan D; Sinha P
    Transfus Apher Sci; 2006 Apr; 34(2):157-61. PubMed ID: 16510315
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hemoglobin and platelet count effect on platelet yields in plateletpheresis.
    Guerrero-Rivera S; Gutiérrez-Espíndola G; Talavera JO; Meillón-García LA; Pedraza-Echevarría M; Pizzuto-Chávez J
    Arch Med Res; 2003; 34(2):120-3. PubMed ID: 12700007
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lowering the hemoglobin cutoff for female plateletpheresis donors.
    Fraser JL; Whatmough A; Uhl L; Kruskall MS
    Transfusion; 1998 Sep; 38(9):855-9. PubMed ID: 9738626
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A questionnaire: will plateletpheresis donors accept multicomponent donation?
    Qendro I; Moog R; Müller N
    Transfus Apher Sci; 2002 Oct; 27(2):95-9. PubMed ID: 12350055
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The relationship of platelet yield, donor's characteristic and apheresis instruments in China.
    Yin G; Xu J; Shen Z; Wang Y; Zhu F; Lv H
    Transfus Apher Sci; 2013 Dec; 49(3):608-12. PubMed ID: 23978555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.